Sigilon Therapeutics
Samuel Andrews currently holds the position of Senior Associate Lab Operations at Sigilon Therapeutics, Inc. since May 2021. Previously, Samuel was a Senior Site Specialist at Thermo Fisher Scientific from January 2017 to November 2020.
Sigilon Therapeutics
2 followers
Sigilon Therapeutics’ mission is to create immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases.